Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + L-arginine + L-carnitine + folic acid + selenium
- Development stage
- Unknown
- Lead developer
- Saltvae Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This oral tablet is a combination nutraceutical product manufactured by Saltvae Pharmaceuticals, primarily indicated for the management of Polycystic Ovary Syndrome (PCOS) and associated female infertility. The formulation combines five active ingredients: myo-inositol, which acts as an insulin sensitizer to improve ovulation and egg quality; L-arginine, which serves as a precursor to nitric oxide to enhance pelvic blood flow; L-carnitine, which supports cellular energy metabolism; folic acid, essential for DNA synthesis and homocysteine regulation; and selenium, which provides antioxidant support. Together, these components target insulin resistance, metabolic dysfunction, and oxidative stress to improve reproductive outcomes and reduce the risk of gestational diabetes in women with PCOS.
- Other names
- Myo-inositol, L-Arginine, L-Carnitine, Folic Acid with Selenium Tablets
02
Targets
SLC7A1 (Cationic amino acid transporter 1)DHFR (Dihydrofolate reductase)NOS1 (nNOS)GPX1 (Glutathione peroxidase 1)
Beyond the preview
Go deeper on myo-inositol + L-arginine + L-carnitine + folic acid + selenium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myo-inositol + L-arginine + L-carnitine + folic acid + selenium.